Prosthetic valve endocarditis: predictors of early outcome of surgical therapy. A multicentric study

Nicola Luciani(Università Cattolica del Sacro Cuore), Eugenio Mossuto(IRCCS Policlinico San Donato), Davide Ricci(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Marco Luciani(Università Cattolica del Sacro Cuore), Marco Russo(University of Rome Tor Vergata), Antonio Salsano(Martin University), Alberto Pozzoli(Vita-Salute San Raffaele University), Michele Danilo Pierri(Ospedali Riuniti di Ancona), Augusto D’Onofrio(Azienda Ospedale - Università Padova), Giovanni Alfonso Chiariello(Università Cattolica del Sacro Cuore), Franco Glieca(Università Cattolica del Sacro Cuore), Alberto Canziani(IRCCS Policlinico San Donato), Mauro Rinaldi(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Paolo Nardi(University of Rome Tor Vergata), Valentina Milazzo(Università Cattolica del Sacro Cuore), Enrico Maria Trecarichi(Università Cattolica del Sacro Cuore), Francesco Santini(Martin University), Michele De Bonis(Vita-Salute San Raffaele University), Lucia Torracca(Ospedali Riuniti di Ancona), Eleonora Bizzotto(Azienda Ospedale - Università Padova), Mario Tumbarello(Università Cattolica del Sacro Cuore)
European Journal of Cardio-Thoracic Surgery
May 13, 2017
Cited by 46Open Access
Full Text

Abstract

OBJECTIVES: Prosthetic valve endocarditis (PVE) is an uncommon yet dreadful complication in patients with prosthetic valves that requires a distinct analysis from native valve endocarditis. The present study aims to investigate independent risk factors for early surgical outcomes in patients with PVE. METHODS: A retrospective cohort study was conducted in 8 Italian Cardiac Surgery Units from January 2000 to December 2013 by enrolling all PVE patients undergoing surgical treatment. RESULTS: A total of 209 consecutive patients were included in the study. During the study period, the global rate of surgical procedures for PVE among all operations for isolated or associated valvular disease was 0.45%. Despite its rarity this percentage increased significantly during the second time frame (2007-2013) in comparison with the previous one (2000-2006): 0.58% vs 0.31% (P < 0.001). Intraoperative and in-hospital mortality rates were 4.3% and 21.5%, respectively. Logistic regression analysis identified the following factors associated with in-hospital mortality: female gender [odds ratio (OR) = 4.62; P < 0.001], shock status (OR = 3.29; P = 0.02), previous surgical procedures within 3 months from the treatment (OR = 3.57; P = 0.009), multivalvular involvement (OR = 8.04; P = 0.003), abscess (OR = 2.48; P = 0.03) and urgent surgery (OR = 6.63; P < 0.001). CONCLUSIONS: Despite its rarity, PVE showed a significant increase over time. Up to now, in-hospital mortality after surgical treatment still remains high (>20%). Critical clinical presentation and extension of anatomical lesions are strong preoperative predictors for poor early outcome.


Related Papers

No related papers found

Powered by citation graph analysis